Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12703/P7-53 http://scihub22266oqcxt.onion/10.12703/P7-53 C4447055!4447055!26097726     free     free     free       F1000Prime+Rep 2015 ; 7 (ä): ä Nephropedia Template TP {{tp|p=26097726|t=2015. Advances in the management of basal cell carcinoma |pdf=|usr=}}{{26097726}} gab.com Text Advances in the management of basal cell carcinoma JO: F1000Prime Rep http://www.kidney.de/pget.php?&tw=1&pmid=26097726 #FOAvip Basal cell carcinoma (BCC), a malignant neoplasm derived from non-keratinizing cells that originate in the basal layer of the epidermis, is the most common cancer in humans. Several factors such as anatomic location, histologic features, primary or recurrent tumors, and patient characteristics influence the choice of treatment modality for BCC. Mohs micrographic surgery (MMS) facilitates optimal margin control and conservation of normal tissue for the management of BCC; however, other treatment modalities may also be implemented in the correct clinical scenario. Other treatment modalities that will be reviewed include simple excision, electrodesiccation and curettage, cryotherapy, topical immunotherapy and chemotherapy, photodynamic therapy, and radiation therapy. In addition, targeted molecular therapeutic options for the treatment of advanced or metastatic BCC will be discussed in this informal review based on recent literature obtained by using PubMed with relevant search terms. Twit Text FOAVip Advances in the management of basal cell carcinoma ????F1000Prime Rep http://www.kidney.de/pget.php?&tw=1&pmid=26097726 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26097726 #FOAvip English Wikipedia <ref>{{Cite pmid|26097726}}</ref> Advances in the management of basal cell carcinoma #MMPMID26097726 Lewin JM; Carucci JA F1000Prime Rep 2015[]; 7 (ä): ä PMID26097726show ga Basal cell carcinoma (BCC), a malignant neoplasm derived from non-keratinizing cells that originate in the basal layer of the epidermis, is the most common cancer in humans. Several factors such as anatomic location, histologic features, primary or recurrent tumors, and patient characteristics influence the choice of treatment modality for BCC. Mohs micrographic surgery (MMS) facilitates optimal margin control and conservation of normal tissue for the management of BCC; however, other treatment modalities may also be implemented in the correct clinical scenario. Other treatment modalities that will be reviewed include simple excision, electrodesiccation and curettage, cryotherapy, topical immunotherapy and chemotherapy, photodynamic therapy, and radiation therapy. In addition, targeted molecular therapeutic options for the treatment of advanced or metastatic BCC will be discussed in this informal review based on recent literature obtained by using PubMed with relevant search terms. äAdvances in the management of basal cell carcinoma (epmc).pdf DeepDyve Pubget Overpricing